IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0257599.html
   My bibliography  Save this article

Efficacy and safety of Qingre-Chushi therapies in active ulcerative colitis: A network meta-analysis

Author

Listed:
  • Ling Zhang
  • Yun-bo Wu
  • Yun-kai Dai
  • Qi Liu
  • Yu-jie Ren
  • Shi-jie Xu
  • Huai-geng Pan
  • Wei-jing Chen
  • Ru-liu Li
  • Ling Hu

Abstract

Background: Ulcerative colitis (UC) is a chronic inflammatory disease with an increasing incidence in the world. Qingre-Chushi therapies (QC) can alleviate clinical symptoms. Therefore, a network meta-analysis was conducted to systematically evaluate the efficacy and safety of QC in the treatment of active UC patients. Methods: 7 databases were screened and relevant randomized controlled trials were selected. The tools of Cochrane Handbook and the GRADE system were conducted to assess the quality of outcomes. Pooled risk ratio or standard mean difference was calculated with 95% credible interval for outcomes measurement using the random-effects model. The surface under the cumulative ranking curve (SUCRA) was performed to rank the treatments. The larger SUCRA scores, the more effective interventions. Results: A total of 3560 articles were identified and 21 studies including 1829 participants were included for further analysis. Totally, 9 therapies regimens were compared: oral mesalazine, mesalazine enema, mesalazine suppository, oral mesalazine + mesalazine enema, oral QC, oral QC + oral mesalazine, QC enema, oral QC + QC enema, and oral mesalazine + QC enema. Based on the SUCRA plot, oral QC + oral mesalazine was the best treatment in inducing clinical response; oral QC + QC enema had the best efficacy in the improvement of Mayo scores and alleviating abdominal pain; oral mesalazine + mesalazine enema was the optimal therapy in the endoscopic improvement and reducing diarrhea; QC enema + oral mesalazine was the best option in preventing bloody stool. Conclusion: This study confirmed the efficacy and safety of QC in treating active UC and suggested that the combination of oral medications with topical can achieve more benefits.

Suggested Citation

  • Ling Zhang & Yun-bo Wu & Yun-kai Dai & Qi Liu & Yu-jie Ren & Shi-jie Xu & Huai-geng Pan & Wei-jing Chen & Ru-liu Li & Ling Hu, 2021. "Efficacy and safety of Qingre-Chushi therapies in active ulcerative colitis: A network meta-analysis," PLOS ONE, Public Library of Science, vol. 16(9), pages 1-17, September.
  • Handle: RePEc:plo:pone00:0257599
    DOI: 10.1371/journal.pone.0257599
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0257599
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0257599&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0257599?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Sofia Buonocore & Philip P. Ahern & Holm H. Uhlig & Ivaylo I. Ivanov & Dan R. Littman & Kevin J. Maloy & Fiona Powrie, 2010. "Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology," Nature, Nature, vol. 464(7293), pages 1371-1375, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jonathan W. Lo & Jan-Hendrik Schroeder & Luke B. Roberts & Rami Mohamed & Domenico Cozzetto & Gordon Beattie & Omer S. Omer & Ellen M. Ross & Frank Heuts & Geraldine M. Jowett & Emily Read & Matthew M, 2024. "CTLA-4 expressing innate lymphoid cells modulate mucosal homeostasis in a microbiota dependent manner," Nature Communications, Nature, vol. 15(1), pages 1-17, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0257599. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.